TNNI3

7-27 cTnI align

TNNI3, also known as Cardiac Troponin I (cTnI), is a protein encoded by the TNNI3 gene in humans. It plays a crucial role in the regulation of cardiac muscle contraction and is a key component of the troponin complex. This complex is responsible for calcium-sensitive interactions between actin and myosin, which are essential for muscle contraction. TNNI3 is specifically expressed in the heart, distinguishing it from other troponin I isoforms found in skeletal muscle.

Function

TNNI3 is part of the troponin complex, which also includes Troponin T (TnT) and Troponin C (TnC). This complex is located on the thin filament of the muscle fibers and plays a critical role in the regulation of muscle contraction and relaxation. Upon binding of calcium to TnC, a conformational change occurs that allows TnI to release its inhibition of actin-myosin interactions, thereby facilitating contraction. TNNI3, in particular, inhibits the ATPase activity of actomyosin in the absence of calcium, preventing muscle contraction.

Clinical Significance

TNNI3 is of significant clinical interest because it is a highly sensitive and specific marker for myocardial infarction (MI) or heart attack. Levels of cTnI in the blood increase significantly within hours of an MI and can remain elevated for up to 1-2 weeks, making it a crucial biomarker for diagnosing cardiac events. Its cardiac specificity is especially valuable in clinical settings for distinguishing between cardiac and non-cardiac causes of chest pain.

Genetic and Molecular Aspects

The TNNI3 gene is located on chromosome 19 in humans and consists of multiple exons that encode the cardiac troponin I protein. Mutations in the TNNI3 gene have been associated with various cardiomyopathies, including hypertrophic cardiomyopathy (HCM) and restrictive cardiomyopathy (RCM). These mutations can affect the protein's structure and function, leading to impaired cardiac muscle contraction and an increased risk of heart failure and sudden cardiac death.

Research and Therapeutic Implications

Research into TNNI3 and its interactions within the troponin complex continues to provide insights into the molecular mechanisms of muscle contraction and its regulation. Understanding these processes at a molecular level is crucial for developing targeted therapies for heart diseases. Moreover, the role of TNNI3 in cardiac diseases has led to the development of therapeutic interventions aimed at modulating its function to treat or manage cardiomyopathies and heart failure.

See Also

• Troponin
• Cardiomyopathy
• Myocardial Infarction
• Heart Failure

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian